25.07.2014 • News • Dede Willams • Merck • Merck Serono

Merck Serono Extends Italian Alliance for Neurodegenerative Diseases

Merck Serono, the biopharmaceuticals arm of Germany's Merck KgaA, is extending by two years its 10-year R&D cooperation with San Raffaele University & Research Hospital for Research in Milan focusing on neurodegenerative diseases.

The partners are aiming at the development of pre-clinical and clinical research projects with a focus on developing innovative therapies against serious and disabling neurological diseases such as multiple sclerosis affecting young adults in particular.

San Raffaele University & Research Hospital are providing know-how and laboratories to develop new therapies and to evaluate the effectiveness of the molecules developed by Merck Serono.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Top-Feature

most read